Exabis Library
Welcome to the e-CCO Library!
P397: Autologous stem cell transplantation in refractory Crohn's disease: evaluation of a modified mobilisation regimen and analyses of the cost-effectiveness
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P397: Can upskilling pharmacy technicians support a robust and cost-effective Inflammatory Bowel Disease patient review process? A single-centre prospective study.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P397: Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P397: Efficacy and safety of sequential rescue therapy with infliximab and tacrolimus in patients with corticosteroid-refractory ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P397: Response to biologics in IBD patients assessed by Computerized image analysis of Probe Based Confocal Laser Endomicroscopy with molecular labeling
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P398 The early appearance of anti-drug antibodies during the induction phase predicts the clinical response of adalimumab and infliximab in IBD
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P398: An objective measure of response to treatment for patients with Crohn's perianal fistulas on anti-TNF treatment
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P398: Cannabis induces clinical and endoscopic improvement in moderately active ulcerative colitis (UC)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P398: Disease clearance: a potential target for management of patients with Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P398: Effect of Intravenous versus Oral Iron Therapy on Physical Fitness and Haemoglobin in Paediatric IBD Patients with Anaemia
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P398: Leptin controls immune cell composition and activity in acquired generalised lipodystrophy with combined Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P398: Long term efficacy and safety of ABP 501 adalimumab biosimilar in inflammatory bowel diseases: preliminary results from the ADASWITCH study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P398: The costs of care for patients with ulcerative colitis: effect of adalimumab on health care resources utilisation in clinical practice from INSPIRADA
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P399 Endoscopic and histologic outcome in tofacitinib treated refractory moderate-to-severe ulcerative colitis: A prospective real-life cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P399: Adverse events associated with azathioprine treatment in Korean pediatric inflammatory bowel disease patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P399: C-Reactive Protein Values After Surgery for Inflammatory Bowel Disease: Is It Still A Good Marker For Intra-Abdominal Complication? A Retrospective Cohort Study of 347 procedures.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P399: Cost-effectiveness of utilising proactive Infliximab therapeutic drug monitoring for inflammatory bowel disease in routine clinical practice
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P399: Detection of iron restricted erythropoiesis in patients with IBD: How can we disentangle effects of inflammation?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P399: Higher anti-tumour necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulising Crohn’s disease: A retrospective multi-centre study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P399: Testing patients initiating anti-TNFα agents for mycobacterial infection using interferon-gamma release assays (IGRA): The combined experience of a large dermatology and Inflammatory Bowel Disease service
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM